Results 131 to 140 of about 50,558 (217)

Nirmatrelvir-Ritonavir-Induced Pancreatitis: A Concern in the COVID Era. [PDF]

ACG Case Rep J
DeBroff J, Abraham J, Yoon BH, Cohen I.
europepmc   +1 more source

Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV. [PDF]

Antimicrob Agents Chemother
van Dyk J, Waitt C, Mugerwa H, Wiesner L, Orrell C, Bamford A, Gibb DM, McIlleron HM, Colbers A, Burger DM, Denti P, Wasmann RE.   +11 more
europepmc   +1 more source

Ethanol-assisted fabrication of Casein-Ritonavir amorphous dispersions. [PDF]

Food Hydrocoll Health
Sharma D, Harte FM.
europepmc   +1 more source

Efficacy and Safety of Nirmatrelvir/Ritonavir and Molnupiravir in Non-Hospitalized Patients with COVID-19: A Single-Center Retrospective Study. [PDF]

Medicina (Kaunas)
Pete M, Lendak D, Kovačević N, Pastornački A, Milovac M, Petrić V.   +5 more
europepmc   +1 more source

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study. [PDF]

Clin Drug Investig
Okoli GN, Lin Y, Wu P, Cowling BJ.
europepmc   +1 more source

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population. [PDF]

Med J Aust
Mudrik-Zohar H, Cutfield T, Morpeth S, Hills T, Duffy E, Edwards LJ, Cheng AC, Tong SYC.   +7 more
europepmc   +1 more source

InfoMedex: drug-drug interaction prediction via a multimodal CNN-transformer model. [PDF]

Front Drug Saf Regul
Disharoon A, Pasupuleti S, Thurston C, Fiore M, McKenzie S, Smith A, Masino AJ.   +6 more
europepmc   +1 more source

Persistent low-level viremia and symptomatic HIV cerebrospinal fluid escape in a person living with HIV receiving darunavir: a case report. [PDF]

Braz J Infect Dis
Suriano ES, Kuslevicius K, Leal MMDS, Relvas LFD, Schneider GAR.   +4 more
europepmc   +1 more source

Nirmatrelvir/Ritonavir Efficacy in Immunocompetent Patients with Confirmed Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2: An Updated Systematic Review and Meta-analysis. [PDF]

J Res Pharm Pract
Khani E, Afsharirad H, Yadegari AT, Zarezadeh M, Asham H, Bannazadeh-Baghi H, Entezari-Maleki T.   +6 more
europepmc   +1 more source

Multiclass HIV drug resistance: Case series of treatment-experienced PLHIV with resistance to all antiretroviral classes in Northern Uganda. [PDF]

IDCases
Kayinda F, Bakunzi LB, Okello E, Jurua C, Nasuuna EM.   +4 more
europepmc   +1 more source